Home
>
References
>
2017
>
Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration.
Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration.
Höglund K, Kern S, Zettergren A, Börjesson-Hansson A, Zetterberg H, Skoog I, Blennow K.
|
Journal
|
|
Translational Psychiatry
|
|
Species
|
|
|
|
Analytes Measured
|
|
|
|
Matrix Tested
|
|
|
|
Year
|
|
2017
|
|
Volume
|
|
7
|
|
Page Numbers
|
|
Journal Page Number(s)
|
|
Application
|
|
|
Abstract
View Publications
Browse Our Products
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters